NEW THERAPEUTIC WITH A SECRETOME MADE FROM MESENCHYMAL STEM CELLS FROM UMBILIORD TISSUE OR WHARTON'S SULM

Abstract

Therapeutic comprising a secretome derived from mesenchymal stem cells from umbilical cord tissue or mesenchymal stem cells from Wharton's jelly tissue, wherein the secretome comprises or consists of the following components: granulocyte colony-stimulating factor (G-CSF); growth-regulated protein alpha (GRO-α); hepatocyte growth factor (HGF); interleukin-6 (IL-6); leukemia-inhibitory factor (LIF); monocyte chemoattractant protein 3 (MCP-3); stem cell growth factor beta (SCGF-β); tissue inhibitor of metalloproteinase 1 (TIMP-1); matrix metalloproteinase 3 (MMP-3); angiopoietin-like protein 4 (ANGPTL4); tumor necrosis factor receptor RI (TNF-RI); and CD63+ exosomes.